Proficio Capital Partners LLC bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,418 shares of the company's stock, valued at approximately $1,933,000. Proficio Capital Partners LLC owned about 0.09% of Addus HomeCare as of its most recent SEC filing.
Several other large investors have also bought and sold shares of ADUS. Quarry LP bought a new position in Addus HomeCare during the 3rd quarter worth $28,000. Smartleaf Asset Management LLC raised its position in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after purchasing an additional 214 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares during the last quarter. KBC Group NV raised its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Addus HomeCare by 34.5% during the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock worth $158,000 after purchasing an additional 323 shares during the last quarter. 95.35% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on ADUS. JMP Securities began coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective for the company. Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. StockNews.com lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Macquarie reissued an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. Finally, Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $132.78.
Read Our Latest Research Report on Addus HomeCare
Addus HomeCare Stock Performance
ADUS traded down $1.07 during midday trading on Friday, reaching $89.83. 434,769 shares of the company were exchanged, compared to its average volume of 148,837. The company's fifty day moving average price is $111.83 and its 200 day moving average price is $121.81. The company has a market cap of $1.63 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 4.60% of the company's stock.
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
